Genetic Predisposition to Breast and Ovarian Cancer: Prospective Study of BRCAx Gene Mutation

NCT03667417 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 5000

Last updated 2020-07-01

No results posted yet for this study

Summary

Cohort of subjects carrying a BRCA gene mutation: genetic predispositions to breast and ovarian cancers

Conditions

Interventions

OTHER

Questionnaires

standardized data collection and 10-year prospective follow-up

Sponsors & Collaborators

  • UNICANCER - Le Groupe génétique et cancer (GGC)

    collaborator UNKNOWN
  • Institut Paoli-Calmettes

    lead OTHER

Principal Investigators

  • Catherine NOGUES, MD · Institut Paoli-Calmettes

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
1999-10-15
Primary Completion
2028-10-15
Completion
2028-10-15

Countries

  • France

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03667417 on ClinicalTrials.gov